these novel synthetic inhibitors , specific for egf-receptor kinase , offer a new method to inhibit egf-stimulated cell proliferation which may be useful in treating specific pathological conditions involving cellular proliferation , including different types of cancers .
C0242275
egf
C0596290
cell proliferation